From October 27 to November 14, 2025, RIBSP specialists – A. Zhakypbek, A. Abdimukhtar, A. Abdylkalyk, M. Almezhánova, and A. Sagimbayeva — successfully completed a three-week training program on GxP quality systems (GMP, GLP, GCP) and biosafety, conducted by the International Vaccine Institute (IVI) in Seoul.
The course included 120 academic hours of lectures, practical sessions, case studies, and a final assessment. The participants gained comprehensive knowledge of GMP, GLP/GCLP, GCP/ICH standards, risk management, the CAPA system, as well as requirements for biological and laboratory safety.
During the training, the specialists visited laboratory and production facilities, including Sartorius Korea Co., Ltd., where they learned about key manufacturing processes.
The acquired knowledge will help strengthen RIBSP ’s internal quality system, improve SOPs, prepare qualification and validation documentation, and enhance compliance with international standards in the development and quality control of biomedical products.
